RE: Finance3 Jul 2025 12:15
'🤔 if the clinical results are as good as we’ve been led to believe then why haven’t these results been used for fast track / accelerated approval? this would help to secure institutional investment. any such approval would bring potential for revenue forward and boost the share price making it easier to fund ongoing trials and pay off the cln.'
its a fine line isn't it? they feel they have something that will end up massive, so the dichotomy is finding a level of funding, whatever that might be, now that suits the current situation whilst the science/data is continually building that would allow a much better deal in say 6 months time.
bizarrely enough i am actually ok with it playing out like this at the moment.
if there was any doubt, any doubt whatsoever, they would just pile in on the first offer that came along and dilute the **** out of it not worrying about later down the line. it feels to me that they are picking their way through various possibilities that work for the company in the long run, yes the long run that most of us are here for.
as the saying goes 'no pain, no gain', there has been a lot of pain over the last few years but i am more confident than ever that the gain, massive gain at that, is around the corner. around the corner for me is 1 -2 years and i can wait.